You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

OPC-12759

Showing 26 - 50 of 156
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Radiation Therapy, Proton Therapy Trial in Guangzhou (Proton radiation therapy)

Enrolling by invitation
  • Solid Tumor
  • +2 more
  • Proton radiation therapy
  • Guangzhou, Guangdong, China
    Varian ProBeam 360
Jun 12, 2023

Organophosphorus Poisoning Trial in Dhaka (Pralidoxime, Atropine)

Recruiting
  • Organophosphorus Poisoning
  • Dhaka, Bangladesh
    Sir Salimullah Medical College Mitford Hospital
Oct 31, 2023

Malignant Tumor of Oropharynx Stage III, Malignant Tumor of Larynx Stage III, Malignant Tumor of Hypopharynx Stage III Trial in

Recruiting
  • Malignant Neoplasm of Oropharynx Stage III
  • +7 more
  • Escalated Dose
  • Standard Dose
  • Kolkata, West Bengal, India
    Tata Medical Centre
Dec 2, 2021

HPV-associated Oropharyngeal Cancer

Recruiting
  • PREDICTIVE BIOMARKERS
  • +2 more
  • HPV-ASSOCIATED OROPHARYNGEAL CANCER
  • Rome, Italy
    "Regina Elena" National Cancer Institute
Oct 19, 2023

HPV, Oropharyngeal Cancer Trial in Houston (Balstilimab)

Not yet recruiting
  • HPV
  • Oropharyngeal Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Tuberculosis Trial in Ogre, Siauliai, Vilnius (Delamanid, Optimized Background Regimen (OBR))

Terminated
Has Results
  • Tuberculosis
  • Ogre, Latvia
  • +2 more
Oct 14, 2021

Healthy Adult Male Trial in Kyusyu Region (OPC-41061)

Completed
Has Results
  • Healthy Adult Male
  • Kyusyu Region, Japan
    (unnamed)
Jun 6, 2021

Adult ADHD Trial in United States (OPC-64005, Atomoxetine, Placebo)

Completed
Has Results
  • Adult Attention Deficit Hyperactivity Disorder
  • Beverly Hills, California
  • +25 more
Sep 30, 2021

Oropharyngeal Cancer, Human Papilloma Virus Trial in Baltimore

Active, not recruiting
  • Oropharyngeal Cancer
  • Human Papilloma Virus
    • Baltimore, Maryland
      Johns Hopkins Hospital
    Mar 29, 2022

    CHF Trial in Kanto (OPC-61815 injection 2mg, OPC-61815 injection 4mg, OPC-61815 injection 8mg)

    Completed
    Has Results
    • Congestive Heart Failure
    • OPC-61815 injection 2mg
    • +4 more
    • Kanto, Japan
      (unnamed)
    Jul 8, 2021

    Osteoarthritis of the Knee Trial in United States (ATTUNE Cementless CR Fixed Bearing, ATTUNE Cementless PS Fixed Bearing)

    Recruiting
    • Osteoarthritis of the Knee
    • ATTUNE Cementless CR Fixed Bearing
    • ATTUNE Cementless PS Fixed Bearing
    • Irvine, California
    • +14 more
    Aug 8, 2022

    Clinical Treatments for Patients With Oropharyngeal Carcinoma

    Recruiting
    • Oropharynx Carcinoma
    • Surgery for early-stage OPC
    • +4 more
    • Shanghai, Shanghai, China
      Department of Otorhinolaryngology, Eye & ENT Hospital
    Apr 18, 2022

    Tumors Trial in Hefei (Proton Therapy System (ProBeam))

    Recruiting
    • Tumors
    • Proton Therapy System (ProBeam)
    • Hefei, Anhui, China
      Anhui Provincial Hospital
    Jul 13, 2022

    CHF Trial in Kumamoto (OPC-61815, Tolvaptan Tab 15 MG)

    Completed
    Has Results
    • Congestive Heart Failure
    • Kumamoto, Japan
      Saiseikai Kumamoto Hospital
    Jul 14, 2021

    Squamous Cell Carcinoma of the Oropharynx, HPV16 Positive Trial in Worldwide (biological, drug, other)

    Recruiting
    • Squamous Cell Carcinoma of the Oropharynx
    • HPV16 Positive
    • ISA101b
    • +2 more
    • Duarte, California
    • +75 more
    Sep 25, 2022

    Head Neck Cancer Trial in Sutton (Adaptive Radiotherapy)

    Recruiting
    • Head and Neck Cancer
    • Adaptive Radiotherapy
    • Sutton, Surrey, United Kingdom
      Head and Neck Unit, Royal Marsden Hospital
    Jul 21, 2021

    Parkinson Trial in Dupnitsa (Opicapone 50 mg, Placebo)

    Recruiting
    • Parkinson
    • Opicapone 50 mg
    • Placebo
    • Dupnitsa, Bulgaria
      Medical Centre "Asklepii", OOD
    Jul 20, 2021

    CHF Trial in Gifu (OPC-61815 injection)

    Completed
    Has Results
    • Congestive Heart Failure
    • OPC-61815 injection
    • Gifu, Japan
      Gifu Prefectural General Medical Center
    Aug 9, 2021

    Carcinomatous Edema Trial in Kansai Region (OPC-41061)

    Completed
    Has Results
    • Carcinomatous Edema
    • Kansai Region, Japan
      (unnamed)
    Feb 24, 2021

    CHF Trial in Fukuoka (OPC-61815 16mg, OPC-61815 32mg, Moxifloxacin)

    Completed
    Has Results
    • Congestive Heart Failure
    • OPC-61815 16mg
    • +3 more
    • Fukuoka, Japan
      Kyusyu Region
    Apr 13, 2021

    Coronary Artery Disease Trial in Shanghai (BuMA Supreme)

    Active, not recruiting
    • Coronary Artery Disease
    • BuMA Supreme
    • Shanghai, China
      Zhongshan Hospital
    Sep 10, 2021

    Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Trial in

    Not yet recruiting
    • Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8
    • Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8
    • Surgery with or without Neck Dissection
    • +2 more
    • Mumbai, Maharashtra, India
      Tata Memorial Hospital
    Nov 22, 2021

    COPD Trial in China, Japan, Korea, Republic of (tetomilast (OPC-6535), )

    Completed
    Has Results
    • Chronic Obstructive Pulmonary Disease
    • tetomilast (OPC-6535)
    • placebo
    • Central China Area, China
    • +8 more
    Apr 5, 2021

    Crohn's Disease Trial in Japan, Korea, Republic of (Placebo, OPC-6535)

    Completed
    Has Results
    • Crohn's Disease
    • Chubu Region, Japan
    • +10 more
    Mar 11, 2021

    Oropharyngeal Cancer Trial in United Kingdom (Cisplatin, Durvalumab, Radiotherapy)

    Recruiting
    • Oropharyngeal Cancer
    • Exeter, Devon, United Kingdom
    • +32 more
    Nov 29, 2021